| __timestamp | Ionis Pharmaceuticals, Inc. | Viking Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 241751000 | 22223073 |
| Thursday, January 1, 2015 | 322292000 | 6966842 |
| Friday, January 1, 2016 | 344320000 | 9000499 |
| Sunday, January 1, 2017 | 374644000 | 13741186 |
| Monday, January 1, 2018 | 414604000 | 19040000 |
| Tuesday, January 1, 2019 | 466000000 | 23559000 |
| Wednesday, January 1, 2020 | 535000000 | 31931000 |
| Friday, January 1, 2021 | 643000000 | 44981000 |
| Saturday, January 1, 2022 | 833000000 | 54234000 |
| Sunday, January 1, 2023 | 899625000 | 63806000 |
Unlocking the unknown
In the competitive landscape of biotechnology, research and development (R&D) spending is a critical indicator of a company's commitment to innovation. Over the past decade, Ionis Pharmaceuticals and Viking Therapeutics have demonstrated contrasting strategies in this domain.
Since 2014, Ionis Pharmaceuticals has consistently increased its R&D investments, with a remarkable 272% growth by 2023. This strategic focus underscores Ionis's dedication to pioneering advancements in RNA-targeted therapeutics.
Viking Therapeutics, while operating on a smaller scale, has also shown a steady increase in R&D spending, growing by approximately 187% over the same period. This reflects their commitment to developing novel therapies for metabolic and endocrine disorders.
In conclusion, both companies highlight the importance of R&D in driving innovation and maintaining a competitive edge in the biotech industry.
Who Prioritizes Innovation? R&D Spending Compared for BioMarin Pharmaceutical Inc. and Ionis Pharmaceuticals, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Ascendis Pharma A/S and Ionis Pharmaceuticals, Inc.
Ionis Pharmaceuticals, Inc. or Verona Pharma plc: Who Invests More in Innovation?
Ionis Pharmaceuticals, Inc. vs Viking Therapeutics, Inc.: SG&A Expense Trends
Research and Development: Comparing Key Metrics for Ionis Pharmaceuticals, Inc. and Amicus Therapeutics, Inc.
R&D Spending Showdown: Ionis Pharmaceuticals, Inc. vs MorphoSys AG
Research and Development Investment: Ionis Pharmaceuticals, Inc. vs Taro Pharmaceutical Industries Ltd.
Research and Development Expenses Breakdown: Ionis Pharmaceuticals, Inc. vs Xencor, Inc.
Viking Therapeutics, Inc. vs Amicus Therapeutics, Inc.: Strategic Focus on R&D Spending
R&D Spending Showdown: Viking Therapeutics, Inc. vs Bausch Health Companies Inc.
Research and Development: Comparing Key Metrics for Viking Therapeutics, Inc. and Novavax, Inc.
Viking Therapeutics, Inc. or Evotec SE: Who Invests More in Innovation?